Document is current
Any future updates will be listed below
-
Authors
Alvarez Jerez, Pilar
Daida, Kensuke https://orcid.org/0000-0002-9177-9587
Grenn, Francis P.
Malik, Laksh https://orcid.org/0000-0002-2498-146X
Miano-Burkhardt, Abigail https://orcid.org/0000-0002-0447-4698
Makarious, Mary B. https://orcid.org/0000-0002-7978-1051
Ding, Jinhui
Gibbs, J. Raphael https://orcid.org/0000-0002-6985-0658
Moore, Anni
Reed, Xylena https://orcid.org/0000-0002-7563-9365
Nalls, Mike A. https://orcid.org/0000-0003-0319-4325
Shah, Syed https://orcid.org/0000-0002-2094-3386
Mahmoud, Medhat
Sedlazeck, Fritz J. https://orcid.org/0000-0001-6040-2691
Dolzhenko, Egor
Park, Morgan
Iwaki, Hirotaka https://orcid.org/0000-0002-8982-7885
Casey, Bradford https://orcid.org/0000-0002-2623-5997
Ryten, Mina https://orcid.org/0000-0001-9520-6957
Blauwendraat, Cornelis https://orcid.org/0000-0001-9358-8111
Singleton, Andrew B.
Billingsley, Kimberley J. https://orcid.org/0000-0002-8003-4029
- License Information
-
More Information
Article History
Received: 29 January 2024
Accepted: 4 July 2024
First Online: 26 July 2024
Competing interests
: M.A.N.‘s participation in this project was part of a competitive contract awarded to DataTecnica LLC by the National Institutes of Health to support open science research. M.A.N. also currently serves on the scientific advisory board for Clover Therapeutics and is a founder at Neuron23 Inc. F.J.S. receives research support from Illumina, O.N.T. and PacBio. E.D. is an employee of Pacific Biosciences. A.B.S. is an editor for npj Parkinson’s Disease. A.B.S. was not involved in the journal’s review of, or decisions related to, this manuscript. The remaining authors declare no competing interests.
